Hasegawa Makoto, Marshall Desiree A, Gonzalez-Cuyar Luis F, Hippe Daniel S, Samy Shar, Maravilla Kenneth R
Department of Radiology, University of Washington, Seattle, WA, USA.
Department of Radiology, Toho University Ohashi Medical Center, Tokyo, Japan.
Acta Radiol. 2022 Mar;63(3):345-350. doi: 10.1177/0284185121994047. Epub 2021 Feb 15.
Generally, studies of gadolinium (Gd) deposition in humans measure concentration by analyzing formalin fixed postmortem tissue. However, the effect of formalin fixation on measured Gd concentration has not been well investigated.
To evaluate the effect of fixation by comparing Gd concentration in fresh versus formalin-fixed postmortem human tissues.
Fresh samples of bone and skin were collected from autopsy cases with previous exposure to Gd-based contrast agents (GBCAs). The type of GBCA administered, dose, and estimated glomerular filtration rate were recorded. Each tissue sample was cut into three aliquots. Paired samples were stored fresh frozen while the remaining two were stored in 10% neutral buffered formalin for one and three months, respectively. Gd concentration was measured using ICP-MS.
Of 18 autopsy cases studied, 12 were exposed to only macrocyclic GBCA, one to only linear agents, and five received both macrocyclic and linear agents. On average, Gd concentration for bone decreased 30.7% after one month of fixation ( = 0.043) compared to non-fixed values. There was minimal, if any, change in concentration between one and three months (average decrease 1.5%; = 0.89). The findings were numerically similar for skin tissue with an average decrease of 36.9% after one month ( = 0.11) and 6.0% ( = 0.73) between one and three months.
Formalin fixation appears to decrease Gd concentration in bone and skin by approximately 30%-40% on average. The largest decrease occurs within the first 30 days of fixation followed by a considerably smaller decrease at 60 days.
一般来说,关于钆(Gd)在人体中沉积的研究是通过分析福尔马林固定的尸检组织来测量浓度的。然而,福尔马林固定对所测钆浓度的影响尚未得到充分研究。
通过比较新鲜与福尔马林固定的人体尸检组织中的钆浓度,评估固定的影响。
从先前接触过钆基造影剂(GBCAs)的尸检病例中采集骨骼和皮肤的新鲜样本。记录所施用的GBCA类型、剂量和估计的肾小球滤过率。每个组织样本被切成三等份。配对样本新鲜冷冻保存,其余两份分别在10%中性缓冲福尔马林中保存1个月和3个月。使用电感耦合等离子体质谱法(ICP-MS)测量钆浓度。
在研究的18例尸检病例中,12例仅接触大环GBCA,1例仅接触线性制剂,5例同时接受大环和线性制剂。平均而言,与未固定的值相比,固定1个月后骨骼中的钆浓度降低了30.7%(P = 0.043)。1个月至3个月之间浓度变化极小(平均降低1.5%;P = 0.89)。皮肤组织的结果在数值上相似,1个月后平均降低36.9%(P = 0.11),1个月至3个月之间降低6.0%(P = 0.73)。
福尔马林固定似乎使骨骼和皮肤中的钆浓度平均降低约30%-40%。最大降幅发生在固定的前30天内,随后在60天时降幅明显较小。